MEDICAL DEVICES Uncommon sensors
Dr Ben Hwang, CEO of Profusa – a leading company working on developing real-time biosensors that track aspects of our overall health status – explains what biosensors could mean for the future of clinical trials.
challenges. Recruiting subjects is difficult, time- consuming and expensive. Retaining them is even harder. Then there is the question of how studies are designed in order to yield the most useful data as quickly as possible, without taking potentially hazardous shortcuts. Biosensors could help overcome those hurdles
C
by swiftly and efficiently putting biochemical data from human subjects into the hands of researchers, without the need for extensive clinical interaction. Our company, Profusa, has developed a tiny,
injectable biosensor that provides continuous, real-time monitoring of biochemical markers. These biosensors, which are relatively inexpensive
linical studies are the bedrock of drug development and medical device innovation, and yet they are fraught with
when deployed at scale, create data streams that don’t rely on in-clinic visits.
How the technology works Unlike conventional sensors made with a sensing electrode wire for glucose monitoring, the Profusa biosensor is made from a tissue-like hydrogel material that is constructed in a fashion that is benign to the body’s foreign body response. Consequently, it does not trigger the hyper- inflammation and scar tissue formation that commonly occurs with traditional sensors. With that advantage, the biosensor – small enough to be injected under the skin via a common hypodermic needle – can safely remain in the body for months or even years, as opposed to days. Its measurements, which come in the form of a fluorescent light signal, are read by a lightweight
68 | Outsourcing in Clinical Trials Handbook
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120